AstraZeneca PLC (AZN)

AstraZeneca PLC (AZN) is a healthcare company (drug manufacturers - general) based in the United Kingdom. The share price is $183.29, down 0.40% on the day, which values the company at $284.27B. Price as of 17 Nov 2026, 17:35 UTC, from Yahoo Finance.

Key facts

Share price
$183.29−0.40% today
Market value
$284.27B
P/E ratio
25.9×last 12 months
Forward P/E
16.2×
Dividend yield
1.76%
Funk Score
72/100
Against its own history
About its usual priceusual price $174.37
200-week average
$153.9419% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

AstraZeneca PLC in more detail

AZN trades at 25.9× its last twelve months' earnings, 16.2× next year's expected earnings, 4.6× sales. Measured against its own history, the price is 5% above what its usual multiples would imply ($174.37) — about its usual price. It sits 19% above its 200-week average of $153.94.

Its Funk Score is 72 out of 100 (financial strength 6.2, profitability 8.0, growth 7.8, value 6.6, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

12 of the superinvestors tracked here hold AZN, including Sarah Ketterer (20.2% of the portfolio), Primecap team (1.8% of the portfolio), Lew Sanders (1.1% of the portfolio).

Superinvestors holding AZN

12 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:AZN vs NVS (AstraZeneca PLC vs Novartis)AZN vs UNH (AstraZeneca PLC vs UnitedHealth Group)AZN vs TMO (AstraZeneca PLC vs Thermo Fisher Scientific)AZN vs MRK (AstraZeneca PLC vs Merck & Co)AZN vs AMGN (AstraZeneca PLC vs Amgen)

All health care companies by market valueLargest companies in the United KingdomAll stocks A–Z

AstraZeneca PLC (AZN): questions and answers

What is AZN's P/E ratio?

AstraZeneca PLC trades at 25.9× its last twelve months' earnings and 16.2× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 28.1× to 64.3×, with a median of 32.2×.

What is AZN's PEG ratio?

AstraZeneca PLC's PEG ratio is 1.33 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is AstraZeneca PLC's market cap?

AstraZeneca PLC is valued at $284.27B at a share price of $183.29.

Is AZN overvalued or undervalued?

Against its own history, AZN is about its usual price: the price is 5% above the $174.37 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is AZN above its 200-week moving average?

Yes. AZN is 19.1% above its 200-week average of $153.94. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is AstraZeneca PLC growing?

Over the last three fiscal years AstraZeneca PLC's revenue grew 9.8% a year and its earnings per share 45.8% a year.

Cite this page

Funkfolio, “AstraZeneca PLC (AZN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/AZN

Underlying data: Yahoo Finance; company filings with the SEC.